Nilsson C, Jiang M, Pettersson K, Iitiä A, Mäkelä M, Simonsen H, Easteal S, Herrera R J, Huhtaniemi I
Department of Biotechnology, University of Turku.
Clin Endocrinol (Oxf). 1998 Sep;49(3):369-76. doi: 10.1046/j.1365-2265.1998.00532.x.
An immunologically anomalous form of LH, due to two point mutations in codons 8 and 15 of the LH beta gene, has previously been described. LH status, i.e. the discrimination between wild-type (WT) and variant (V) LH, is usually determined by immunoassays, which can be unreliable at low serum concentrations of LH. A DNA hybridization assay was therefore developed to score the LH genotype in all subjects, independent of their serum LH concentrations. To evaluate the performance of the hybridization method, and to expand our observations of the worldwide occurrence of the V-LH, we determined its frequency in additional populations. To confirm the connection between the anomalous immunoreactivity and the V-LH beta gene, we also sequenced the LH beta subunit gene of a homozygous person.
According to the ratio of two immunoassays, one detecting only WT-LH and the other detecting equally WT and V-LH, individuals can be classified as homozygotes for the V-LH beta allele, heterozygotes or WT. DNA samples from persons with known LH status, according to the immunoassays, were used for the development and evaluation of a new allele-specific DNA hybridization assay. This assay, and PCR and restriction fragment length polymorphism analysis, were used to determine the frequency of the V-LH beta allele in DNA samples obtained from eight populations.
Ambulatory adult men and women, apparently healthy and with no endocrine disorders.
The LH genotyping by immunoassays and by the new hybridization method gave identical results with all samples analysed (n = 25). The V-LH beta subunit was observed to always have the two point mutations, and to be identical with the ones previously reported. The V-LH beta carrier frequency in the DNA samples collected from various populations varied between 0 and 53.5%.
The immunoassay technique and the hybridization assay can be used as alternatives to determine the LH status. A great variation in carrier frequency of the V-LH beta allele is observed in different populations.
先前已描述了一种免疫异常形式的促黄体生成素(LH),其由LHβ基因密码子8和15中的两个点突变引起。LH状态,即野生型(WT)和变异型(V)LH之间的区分,通常通过免疫测定来确定,而在低血清LH浓度时免疫测定可能不可靠。因此开发了一种DNA杂交测定法,以对所有受试者的LH基因型进行评分,而不依赖于他们的血清LH浓度。为了评估杂交方法的性能,并扩展我们对V-LH在全球范围内出现情况的观察,我们确定了其在其他人群中的频率。为了证实异常免疫反应性与V-LHβ基因之间的联系,我们还对一名纯合子的LHβ亚基基因进行了测序。
根据两种免疫测定的比率,一种仅检测WT-LH,另一种同等检测WT和V-LH,个体可被分类为V-LHβ等位基因的纯合子、杂合子或WT。根据免疫测定具有已知LH状态的人的DNA样本用于开发和评估一种新的等位基因特异性DNA杂交测定法。该测定法以及聚合酶链反应(PCR)和限制性片段长度多态性分析被用于确定从八个群体获得的DNA样本中V-LHβ等位基因的频率。
门诊成年男性和女性,表面健康且无内分泌疾病。
通过免疫测定和新的杂交方法对LH进行基因分型,对所有分析的样本(n = 25)得到了相同的结果。观察到V-LHβ亚基总是具有这两个点突变,并且与先前报道的相同。从不同群体收集的DNA样本中V-LHβ携带者频率在0至53.5%之间变化。
免疫测定技术和杂交测定法可作为确定LH状态的替代方法。在不同群体中观察到V-LHβ等位基因携带者频率存在很大差异。